Skip to main content
Nicholas Metrus, MD, Neurology, Summit, NJ, Morristown Medical Center

NicholasRobertMetrusMD

Neurology Summit, NJ

Neurooncology

Neuro Oncologist

Dr. Metrus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Metrus' full profile

Already have an account?

Summary

  • Dr. Nicholas Metrus is a neurologist/neuro-oncologist with Atlantic
    Medical Group Neuroscience Associates. He is a specialist in the diagnosis and treatment of patients
    with brain tumors and conditions of the central nervous system. Dr. Metrus is part of a medical team
    that works together to provide exceptional personalized care for every patient using a multidisciplinary
    and comprehensive approach. His commitment to individualized care includes designing and
    overseeing each patient’s treatment plan, which can include any combination of chemotherapy, target
    therapy, and immunotherapy.

    Throughout his medical education, Dr. Metrus devoted his time to cutting-edge research and
    publishing his work on topics such as paraneoplastic disorders, tumefactive multiple sclerosis, and
    clinical trial enrollment, to name a few. He has also published book chapters on ependymomas and
    advances in clinical trial design for brain tumors. He pursed his fellowship training in neuro-oncology
    at MD Anderson Cancer Center, where he was the 2018 recipient of a research grant, the William
    James Miller Endowed Fellowship Award, for his work in Guillain Barre Syndrome following stem
    cell transplants, and again in 2019 for his description of unique presentations of cancer in the brain.
    His research on hypermutator gliomas has been presented at national and international medical
    conferences. Dr. Metrus earned his medical degree from the American University of the Caribbean and
    went on to complete his residency in neurology at the University of Texas Medical Branch.
    Dr. Metrus is a participating provider of the Atlantic Accountable Care Organization.

Education & Training

  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsResidency, Neurology, 2013 - 2016
  • American University of the Caribbean School of Medicine
    American University of the Caribbean School of MedicineClass of 2013

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2019 - 2025
  • PA State Medical License
    PA State Medical License 2017 - 2024
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • William James Miller Endowed Fellowship Award MD Anderson Cancer Center, 2017-2018, 2018-2019

Publications & Presentations

PubMed

Journal Articles

  • RMB10 truncation in astroblastoma in a patient with history of mandibular ameloblastoma: a case report.  
    Majd N, Metrus NR, Santos-Pinheiro F, Trevino CR, Fuller GN, Huse JT, Chung C, Letonen L, Anderson MD, Penas-Prado M, Cancer Genetics, 2/2019
  • The natural course of hypermutator gliomas.  
    Kamiya-Matsuoka C, Metrus NR, Shaw KR, Penas-Prado M, Weathers SS, Loghin ME, Alfaro-Munoz K, Yuan Y, O’Brien BJ, Harrison RA, Yung WKA, Meric-Bernstam F, De Groot JF, Journal of Clinical Oncology, 5/20/2018
  • Prognosis and outcomes in ependymal tumors  
    Metrus N, Cachia D, Int J Med Biol Front., 2016
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Improvement of leptomeningeal disease following infectious meningitis
    Metrus NR, Kamiya-Matsuoka C, Weathers S, Seligman C, O’Brien B, Society of Neuro Oncology, Phoenix, AZ, 11/2019
  • Is immuno-oncology therapy effective in hypermutator glioblastomas with somatic or germline mutations?
    Kamiya-Matsuoka C, Metrus NR, Weathers S, Shaw KR, Penas Prado M, Loghin M, Alfaro-Munoz K, Obrien B, Majd M, Yung WKA, Meric F, Hambardzumyan D, De Groot J, ESMO, Barcelona, Spain, 2019
  • Isolated CNS blastic plasmacytoid dendritic cell neoplasm in a patient with AML
    Metrus NR, Harrison R, Ferguson S, Weathers S., American Academy of Neurology, Philadelphia, PA, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations